Polynovo Ltd has released a press release.
FDA 510(k) clearance for NovoSorb MTX
Filed with ASX ·
Watch Polynovo's latest callPolynovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Polynovo (ASX:PNV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Polynovo
- Trading halt
- Pause in trading
- PolyNovo FY22 Briefing Session
- FY22 Results Presentation
- Appendix 4E and FY22 Financial Statements
Later from Polynovo
- Q1 FY23 Sales Result
- Chairman and CEO - AGM address to shareholders
- Investor Presentation
- Capital Raising
- Completion of $30m Institutional Placement
Follow Polynovo into a list and get an email when it puts out news.
Follow Polynovo